<DOC>
	<DOCNO>NCT00768495</DOCNO>
	<brief_summary>This trial collect tissue oxygenation data via hyperspectral image endovascular procedure .</brief_summary>
	<brief_title>Hyperspectral Imaging Pre Post Endovascular Intervention</brief_title>
	<detailed_description>This nonrandomized , nonblinded , prospective observational study correlate result obtain traditional measure success endovascular revascularization peripheral artery treatment chronic limb ischemia ; i.e. , ABPI , PVR oxyhemoglobin ( OxyHb ) deoxyhemoglobin ( DeoxyHb ) measurement obtain new imaging device manufacture HyperMed Inc ( OxyVu ) use hyperspectral technology .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<criteria>1 . Patients establish diagnosis lower limb ischemic base symptom claudication , rest pain , nonhealing ulcer gangrene vascular laboratory test currently use make diagnosis schedule endovascular revascularization . 2 . Age group 5085 3 . Gender Male Female 4 . Race race ethnicities 1 . Patients know cardiac disease new MI ( within 3 month ) . 2 . Patients hypertension systolic BP &gt; 200 diastolic BP &gt; 110 day test 3 . Patients supplemental O2 chronic obstructive lung disease 4 . Bedridden subject either due chronic disability neurological problem</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>revascularization</keyword>
	<keyword>claudication</keyword>
	<keyword>hyperspectral</keyword>
	<keyword>oxygenation</keyword>
	<keyword>limb ischemia</keyword>
</DOC>